To identify a unique subset of patients resistant to acute kidney injury (AKI) despite exposure to septic shock, using kidney biomarkers KIM-1 and [TIMP-2]•[IGFBP7], and to explore the clinical significance of this identification.
Key Findings:
Identified a subset of patients with high [TIMP-2]•[IGFBP7] but no AKI, suggesting resilience against kidney injury, which may inform future risk stratification.
Patients classified as AKI-resistant had different baseline characteristics compared to those with AKI and those at reduced risk, indicating potential pathways for targeted interventions.
Interpretation:
The findings suggest that certain patients may possess inherent resilience to AKI in the context of septic shock, which could inform future therapeutic strategies aimed at enhancing this resilience.
Limitations:
Retrospective nature of the study may introduce biases, such as selection bias and confounding factors.
Generalizability may be limited to similar patient populations, necessitating further validation in diverse cohorts.
Conclusion:
Identifying AKI-resistant patients could lead to targeted interventions and improve outcomes in septic shock management.
